Cargando…

Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern

Existing assays to measure antibody cross-reactivity against different SARS-CoV-2 spike (S) protein variants lack the discriminatory power to provide insights at the level of individual clones. Using a mass spectrometry-based approach we are able to monitor individual donors’ IgG1 clonal responses f...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Rijswijck, Danique M. H., Bondt, Albert, Hoek, Max, van der Straten, Karlijn, Caniels, Tom G., Poniman, Meliawati, Eggink, Dirk, Reusken, Chantal, de Bree, Godelieve J., Sanders, Rogier W., van Gils, Marit J., Heck, Albert J. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568977/ https://www.ncbi.nlm.nih.gov/pubmed/36243713 http://dx.doi.org/10.1038/s41467-022-33899-1

Ejemplares similares

A Direct MS-Based Approach to Profile Human Milk Secretory Immunoglobulin A (IgA1) Reveals Donor-Specific Clonal Repertoires With High Longitudinal Stability
por: Bondt, Albert, et al.
Publicado: (2021)

Optimization of Anti-SARS-CoV-2 Neutralizing Antibody Therapies: Roadmap to Improve Clinical Effectiveness and Implementation
por: van der Straten, Karlijn, et al.
Publicado: (2022)

Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron
por: van der Straten, Karlijn, et al.
Publicado: (2022)

Human plasma IgG1 repertoires are simple, unique, and dynamic
por: Bondt, Albert, et al.
Publicado: (2021)

Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
por: Caniels, Tom G., et al.
Publicado: (2021)

Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual
por: Guerra, Denise, et al.
Publicado: (2023)

Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection
por: Lavell, A.H. Ayesha, et al.
Publicado: (2022)

Human Milk from Previously COVID-19-Infected Mothers: The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity
por: van Keulen, Britt J., et al.
Publicado: (2021)

A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike
por: van der Velden, Yme U., et al.
Publicado: (2022)

Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
por: van Gils, Marit J., et al.
Publicado: (2022)

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
por: Schriek, Angela I., et al.
Publicado: (2022)

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
por: Schriek, Angela I., et al.
Publicado: (2022)

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
por: Radić, Laura, et al.
Publicado: (2023)

A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern
por: van Gils, Marit J., et al.
Publicado: (2021)

Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination
por: Appelman, Brent, et al.
Publicado: (2021)

Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses
por: Brinkkemper, Mitch, et al.
Publicado: (2022)

Selectivity over coverage in de novo sequencing of IgGs
por: den Boer, Maurits A., et al.
Publicado: (2020)

Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
por: Grobben, Marloes, et al.
Publicado: (2021)

A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
por: Brinkkemper, Mitch, et al.
Publicado: (2021)

A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
por: Claireaux, Mathieu, et al.
Publicado: (2022)

The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study
por: Wynberg, Elke, et al.
Publicado: (2022)

High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages
por: Hoepel, Willianne, et al.
Publicado: (2021)

Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses
por: Yin, Victor, et al.
Publicado: (2021)

Historical Aspects of Polyclonal IgG Preparations
por: Wahn, Volker, et al.
Publicado: (2017)

Identification of common and distinct origins of human serum and breastmilk IgA1 by mass spectrometry-based clonal profiling
por: Dingess, Kelly A., et al.
Publicado: (2022)

Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentrates
por: Späth, Peter J.
Publicado: (2017)

Influenza A Virus Hemagglutinin Trimer, Head and Stem Proteins Identify and Quantify Different Hemagglutinin-Specific B Cell Subsets in Humans
por: Aartse, Aafke, et al.
Publicado: (2021)

Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection
por: van Paassen, Pien M., et al.
Publicado: (2023)

Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
por: Brouwer, Philip J.M., et al.
Publicado: (2021)

Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19
por: Smit, Wouter L., et al.
Publicado: (2022)

Polyclonal hyperviscosity syndrome in IgG4-related disease and associated conditions
por: Chen, Luke YC, et al.
Publicado: (2015)

Trace N-glycans including sulphated species may originate from various plasma glycoproteins and not necessarily IgG
por: Lauc, Gordan, et al.
Publicado: (2018)

Convergent HIV-1 Evolution upon Targeted Destabilization of the gp120-gp41 Interface
por: Torrents de la Peña, Alba, et al.
Publicado: (2021)

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
por: Brouwer, Philip J. M., et al.
Publicado: (2020)

Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease
por: Culver, Emma L, et al.
Publicado: (2015)

A methodological approach for production and purification of polyclonal antibody against dog IgG
por: Sadeghi, Somayeh, et al.
Publicado: (2018)

MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc N-Glycosylation
por: Sénard, Thomas, et al.
Publicado: (2020)

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
por: van Leeuwen, Leanne P.M., et al.
Publicado: (2022)

Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
por: Derking, Ronald, et al.
Publicado: (2021)

Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation
por: Quast, Isaak, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_755s1asu37cv1nf6nru27ivfp0